Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase II

NCT02347098 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT02347098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02347098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase II
Lead sponsor
VA Office of Research and Development
Phase
Phase 3
Overall status
Completed
Start date
March 30, 2015
Completion date
September 30, 2019
Enrollment
270 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary artery syndrome